États-Unis · Plateformes & données · MarketBeat

What United States Antimony (UAMY) Said on Its Q3 Earnings Call

Publié par MarketBeat · États-Unis il y a 34 min

Image from MarketBeat Media, LLC. · MarketBeat

Résumé détaillé

United States Antimony (NYSE:UAMY) reported higher third-quarter revenue and a wider gross margin as increased sales volumes helped offset declining antimony prices, but the company posted a net loss amid exploration spending and a noncash investment loss. The company also replaced its revenue guid

Lire l'article complet sur MarketBeat Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.marketbeat.com)

What United States Antimony (UAMY) Said on Its Q3 Earnings Call

Résumé détaillé

À lire aussi

Fortress Biotech GAAP EPS of -$0.23 beats by $0.04, revenue of $19.16M misses by $2.41M

How Much Is Nvidia Stock Worth Without Jensen Huang?

The science of vaccines is rapidly advancing — despite the anti-vax movement

Stifel cuts EyePoint stock price target on trial setbacks

Novo Nordisk Seeks FDA, EMA Approval For Sickle Cell Disease Treatment – Here Are The Key Takeaways

If you invested $1,000 in XRP the day Ripple beat SEC, here’s what it’s worth now

What United States Antimony (UAMY) Said on Its Q3 Earnings Call

Résumé détaillé

Partager

À lire aussi

Fortress Biotech GAAP EPS of -$0.23 beats by $0.04, revenue of $19.16M misses by $2.41M

How Much Is Nvidia Stock Worth Without Jensen Huang?

The science of vaccines is rapidly advancing — despite the anti-vax movement

Stifel cuts EyePoint stock price target on trial setbacks

Novo Nordisk Seeks FDA, EMA Approval For Sickle Cell Disease Treatment – Here Are The Key Takeaways

If you invested $1,000 in XRP the day Ripple beat SEC, here’s what it’s worth now